Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : électronique
Auteur(s) : Rollinson, David
Titre(s) : Advances in Parasitology [Texte électronique]
Publication : Burlington : Elsevier Science, 2014
Description matérielle : 1 online resource (303 pages)
Note(s) : 11.4. Treatment of patients with ophthalmologic manifestations. - Print version record.
First published in 1963, Advances in Parasitology contains comprehensive and up-to-date
reviews in all areas of interest in contemporary parasitology. Advances in Parasitology
includes medical studies on parasites of major influence, such as Plasmodium falciparum
and trypanosomes. The series also contains reviews of more traditional areas, such
as zoology, taxonomy, and life history, which shape current thinking and applications.
Eclectic volumes are supplemented by thematic volumes on various topics, including
control of human parasitic diseases and global
Identifiants, prix et caractéristiques : ISBN 9780128000991
Identifiant de la notice : ark:/12148/cb44639657g
Notice n° :
FRBNF44639657
(notice reprise d'un réservoir extérieur)
Table des matières : Front Cover; Advances in Parasitology; Copyright; Contents; Contributors; Memoriam;
Chapter One: Joint Infectious Causation of Human Cancers; 1. Introduction; 2. Essential
and Exacerbating Causes; 3. Joint Essential Causes; 3.1. Background; 3.2. Hepatitis
B virus and hepatitis C virus; 4. Essential with Exacerbating Infections; 4.1. Overview;
4.2. Human immunodeficiency virus; 4.3. Hepatitis D and B viruses; 4.4. Cancers caused
by trematodes; 5. Joint Exacerbating Infections; 6. Uncertainties in Assignment of
Exacerbating and Essential Causation; 6.1. Overview; 6.2. Endogenous retroviruses.
6.3. Burkitt ́s lymphoma7. Implications for Cancers of Uncertain Cause; 7.1. Overview;
7.2. Breast cancer; 8. Implications for the Control of Cancer; Acknowledgements; References;
Chapter Two: Neurological and Ocular Fascioliasis in Humans; 1. Introduction; 2. Fasciola
Infection in Humans; 2.1. Sources of human infection, intraorganic migration, and
lifespan; 2.2. Pathology, symptomatology, and disease periods; 2.2.1. Invasive period
or acute phase; 2.2.2. Biliary period; 2.3. Laboratory analyses; 2.4. Final microhabitat
finding and ectopic infections; 3. Neurological Fascioliasis.
3.1. Distribution and frequency3.2. Types of cases; 4. Neurofascioliasis or Intracranial
Fascioliasis; 5. Fascioliasis with Neurological Implications; 5.1. Minor symptoms;
5.2. Major manifestations; 5.3. Cases with genuine neurological manifestations; 5.4.
Meningeal cases; 5.5. Psychiatric or neuropsychic cases; 5.6. Brain examination techniques
and neuroimaging; 6. Ocular Fascioliasis; 6.1. Distribution and frequency; 6.2. Ophthalmofascioliasis
and indirect ocular affection; 6.3. The first reports of a human ocular infection;
6.4. Manifestations in ophthalmofascioliasis.
6.5. Ocular disorders in indirect affection7. Affection of Related or Close Organs;
7.1. Dorsal spine; 7.2. Pulmonary manifestations; 7.3. Heart and vessel affection;
7.4. Findings in blood vessels; 7.5. Skin and dermatologic reactions; 7.6. Ectopic
mature flukes and upper body locations; 8. Polymorphisms, Multifocality, Manifestation
Changes, and Syndromes; 9. Pathogenic and Physiological Mechanisms; 9.1. Ectopic flukes
as causal agents; 9.2. Physiopathogenic processes indirectly affecting the central
nervous system; 10. Diagnosis of Neurological and Ophthalmologic Fascioliasis.
10.1. Clinical and paraclinical diagnosis10.2. Eosinophilia in the blood and cerebrospinal
fluid; 10.3. Differential diagnosis from other parasitic infections; 10.4. Helminthiases;
10.5. Myiases; 10.6. Fascioliasis diagnosis; 10.7. Fluke and/or fluke egg recovery
by surgery; 10.8. Analyses with faecal samples; 10.9. Analyses with blood samples;
11. Neurological and Ophthalmologic Fascioliasis Treatment; 11.1. Treatment of patients
with neurological manifestations; 11.2. Antiparasitic drugs used in neurological patients;
11.3. Prognosis, sequelae, and fatal cases.
